News
UCB to license its AI technology that improves identification of Osteoporosis to ImageBiopsy Lab
UCB announced a strategic out-licensing of Artificial Intelligence (AI) based fracture identification technology, BoneBot, to ImageBiopsy Lab to bring the new identification tool to...
Press Releases
Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA
Johnson & Johnson announced the U.S. FDA has issued Emergency Use Authorization (EUA) for a booster dose of the Johnson & Johnson COVID-19 vaccine...
News
Greenphire Assembles Clinical Trial Industry Icons, Sponsors, CROs, Sites and Patients to Present at Inaugural Patient Convenience Summit
Greenphire, the global leader in financial lifecycle management for clinical trials, today announced that it is hosting its inaugural patient convenience summit on Oct....
News
Gerresheimer AG on growth course
Gerresheimer AG further accelerated its revenue growth in the third quarter of 2021. “The third quarter once again shows the success of our growth...
News
Chiesi Research Centre: 10 years scientific innovation serving the community
The Chiesi Research Centre celebrates its 10th anniversary. The Group’s main research hub covers 20,000 square metres, a building which was inaugurated in October...
Drug Research
Enesi Pharma inks pact with NIH to evaluate ImplaVax-enabled flu vaccines
Enesi Pharma has entered into an agreement with the US National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to...
Drug Research
Silence and Hansoh partner to develop siRNA-based treatments
Silence Therapeutics and Hansoh Pharmaceutical have entered a partnership to develop small-interfering ribonucleic acid (siRNAs) drugs for three undisclosed targets using the former’s mRNAi...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read